Malignant risk index in evaluation of menopausal ovarian cystic and cystic-solid tumors

VernacularTitle:恶性风险指数对绝经期卵巢囊性及囊实性肿瘤评估的价值
Author: Wenli WANG ¹ ; Yun LIU ; Hua DUAN
Author Information

1. 首都医科大学附属北京妇产医院妇科微创中心 100006
Keywords: Menopause; Ovarian cysts; Risk of malignancy index
From: Chinese Journal of General Practitioners 2019;18(5):482-484
CountryChina
Language:Chinese
Abstract: Clinical data of 349 patients with postmenopausal ovarian cystic and cystic solid tumors undergoing surgical treatment in Beijing Obstetrics and Gynecology Hospital affiliated to Capital Medical University from May 2013 to May 2017 were retrospectively analyzed.Postoperative pathology confirmed 100 cases of malignant tumor,228 cases of benign tumor,and 21 cases of borderline tumor.The malignant risk index (RMI) score was calculated based on the preoperative pelvic ultrasound and serum CA125 level,and the score＜200 was classified as benign tumors and ≥200 as malignant tumors.The postoperative pathological results were used as gold standard,the sensitivity,specificity,accurate rate of RMI in diagnosis of malignant tumors was 0.840(84/100),0.987 (225/228) and 94.2％ (309/328),respectively.The consistency of RMI with pathological diagnosis was high (Kappa=0.858,P＜0.05).The study suggests that RMI has a high degree of credibility for the evaluation of postmenopausal ovarian cystic and cystic solid tumors.